You are here » Home » Companies » Company Overview » Neuland Laboratories Ltd

Neuland Laboratories Ltd.

BSE: 524558 Sector: Health care
NSE: NEULANDLAB ISIN Code: INE794A01010
BSE LIVE 15:40 | 02 Dec 1023.90 -4.55
(-0.44%)
OPEN

1020.00

HIGH

1033.15

LOW

1011.05

NSE LIVE 15:30 | 02 Dec 1023.85 -2.30
(-0.22%)
OPEN

1010.25

HIGH

1034.90

LOW

1009.55

OPEN 1020.00
PREVIOUS CLOSE 1028.45
VOLUME 4197
52-Week high 1105.00
52-Week low 493.50
P/E 27.55
Mkt Cap.(Rs cr) 909.22
Buy Price 0.00
Buy Qty 0.00
Sell Price 0.00
Sell Qty 0.00
OPEN 1020.00
CLOSE 1028.45
VOLUME 4197
52-Week high 1105.00
52-Week low 493.50
P/E 27.55
Mkt Cap.(Rs cr) 909.22
Buy Price 0.00
Buy Qty 0.00
Sell Price 0.00
Sell Qty 0.00

About Neuland Laboratories Ltd.

Neuland Laboratories Ltd

Set up in 1984 as a private limited company to manufacture bulk drugs, Neuland Laboratories (NLL) is promoted by D R Rao. Neuland Drugs & Pharmaceuticals Pvt Ltd, a company set up by the same promoters to manufacture bulk drugs was merged with NLL with effect from Apr.'92. NLL manufactures bulk drugs such as salbutamol sulphate, terbutaline sulphate, labetalol hydrochloride and ciprofloxacin. ...> More

Neuland Laboratories Ltd - Key Fundamentals

Parameter Values
Market Cap ( cr)   909
EPS - TTM () [*S] 37.16
P/E Ratio (X) [*S] 27.55
Face Value ()   10
Latest Dividend (%)   20.00
Latest Dividend Date 04 Aug 2016
Dividend Yield (%) 0.20
Book Value / Share () [*S] 228.90
P/B Ratio () [*S] 4.47
[*C] Consolidated     [*S] Standalone

Neuland Laboratories Ltd - Financial Results

Particulars ( cr) Sep 2016 Sep 2015 % Chg
Net Sales 149.59 128.18 16.7
Other Income -0.06 -0.02 -200
Total Income 149.53 128.16 16.67
Total Expenses 124.38 108.66 14.47
Operating Profit 25.16 19.5 29.03
Net Profit 10.39 6.2 67.58
Equity Capital 8.95 8.95 -
> More on Neuland Laboratories Ltd Financials Results

Neuland Laboratories Ltd - Peer Group

Company Price() Chg (%) Mkt Cap ( CR)
Aarti Drugs 645.40 -0.11 1563.16
Morepen Labs. 23.10 -1.28 1039.15
Alembic 35.75 -1.24 954.70
Neuland Labs. 1023.90 -0.44 909.22
RPG LifeScience. 480.60 -2.39 794.79
SMS Pharma. 92.45 -1.23 783.05
Amrutanjan Healt 526.60 -0.26 768.84
> More on Neuland Laboratories Ltd Peer Group

Neuland Laboratories Ltd - SHAREHOLDING PATTERN

Category Share (%)
Promoters 51.69
Banks/FIs 0.10
FIIs 3.68
Insurance 0.00
Mutual Funds 5.23
Indian Public 30.80
Custodians 0.00
Other 8.47
> More on Neuland Laboratories Ltd Share Holding Pattern

Neuland Laboratories Ltd - RETURNS

Period BSE NSE Sensex NIFTY
1 Week 1.85% 2.09% -0.33% -0.34%
1 Month 5.38% 3.25% -4.71% -4.69%
3 Month 0.55% 0.68% -8.07% -8.21%
6 Month 28.68% 29.33% -2.28% -1.63%
1 Year 46.06% 45.52% 0.43% 2.83%
3 Year 302.46% 297.53% 25.52% 30.39%

Neuland Laboratories Ltd - STOCK STRENGTH

Today's Low/High 1011.05
1033.15
Week Low/High 976.15
1105.00
Month Low/High 918.70
1105.00
YEAR Low/High 493.50
1105.00
All TIME Low/High 13.63
1105.00

Upgrade To Premium Services

Welcome User

Business Standard is happy to inform you of the launch of "Business Standard Premium Services"

As a premium subscriber you get an across device unfettered access to a range of services which include:

  • Access Exclusive content - articles, features & opinion pieces
  • Weekly Industry/Genre specific newsletters - Choose multiple industries/genres
  • Access to 17 plus years of content archives
  • Set Stock price alerts for your portfolio and watch list and get them delivered to your e-mail box
  • End of day news alerts on 5 companies (via email)
  • NEW: Get seamless access to WSJ.com at a great price. No additional sign-up required.
 

Premium Services

In Partnership with

 

Dear Guest,

 

Welcome to the premium services of Business Standard brought to you courtesy FIS.
Kindly visit the Manage my subscription page to discover the benefits of this programme.

Enjoy Reading!
Team Business Standard